Cargando…

Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate

BACKGROUND: Concern for the development of extrapyramidal side effects (EPSEs) represents a barrier to the routine use of long-acting injectable (LAI) antipsychotic medication in patients with first-episode schizophrenia (FES). Flupenthixol decanoate is a first-generation antipsychotic, which is rea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joubert, Francois-Pierre, Chiliza, Bonginkosi, Emsley, Robin, Asmal, Laila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AOSIS 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876946/ https://www.ncbi.nlm.nih.gov/pubmed/33604077 http://dx.doi.org/10.4102/sajpsychiatry.v27i0.1568

Ejemplares similares

Erratum: Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
por: Joubert, Francois-Pierre, et al.
Publicado: (2021)

Neurological Soft Signs, Spontaneous and Treatment Emergent Extrapyramidal Syndromes in Black Africans With First Episode Schizophrenia
por: Ojagbemi, Akin, et al.
Publicado: (2018)

Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia
por: Benelmokhtar, Jebril M., et al.
Publicado: (2021)

Cognitive-perceptual deficits and symptom correlates in first-episode schizophrenia
por: Olivier, Riaan M., et al.
Publicado: (2017)

Early recovery in the first 24 months of treatment in first-episode schizophrenia-spectrum disorders
por: Phahladira, Lebogang, et al.
Publicado: (2020)

The nature of relapse in schizophrenia
por: Emsley, Robin, et al.
Publicado: (2013)

Instruments Measuring Blunted Affect in Schizophrenia: A Systematic Review
por: Kilian, Sanja, et al.
Publicado: (2015)

F106. STATE AND TRAIT RELATED NATURE OF INSIGHT IMPAIRMENT IN SCHIZOPHRENIA
por: Phahladira, Lebogang, et al.
Publicado: (2018)

M122. DEPRESSION IN SCHIZOPHRENIA SPECTRUM DISORDERS: LONGITUDINAL COURSE AND THE RELATIONSHIP WITH OTHER CLINICAL PARAMETERS AND QUALITY OF LIFE
por: Phahladira, Lebogang, et al.
Publicado: (2020)

S108. ASSOCIATIONS BETWEEN GLOBAL BRAIN MEASURES AND STATE- AND TRAIT- RELATED SYMPTOM EXPRESSION OF SCHIZOPHRENIA
por: Asmal, Laila, et al.
Publicado: (2018)

Antipsychotic treatment effects and structural MRI brain changes in schizophrenia
por: Emsley, Robin, et al.
Publicado: (2023)

Factors Moderating the Relationship Between Childhood Trauma and Premorbid Adjustment in First-Episode Schizophrenia
por: Kilian, S., et al.
Publicado: (2017)

Associations of premorbid adjustment with type and timing of childhood trauma in first-episode schizophrenia spectrum disorders
por: Smit, Anna M., et al.
Publicado: (2021)

T148. FIRST EPISODE PSYCHOSIS, TRAUMA AND SUBSTANCE USE IN A HIGH HIV PREVALENCE SETTING IN SUB-SAHARAN AFRICA
por: Ntlantsana, Vuyokazi, et al.
Publicado: (2020)

T86. RELEVANCE OF CANNABIS USE AS A PREDICTOR OF CLINICAL OUTCOME IN FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDER PATIENTS OVER 24 MONTHS OF TREATMENT
por: Scheffler, Frederika, et al.
Publicado: (2020)

S201. HIPPOCAMPAL SUBFIELD VOLUMES AND CHANGE IN BODY MASS OVER 12 MONTHS OF TREATMENT IN FIRST-EPISODE SCHIZOPHRENIA SPECTRUM DISORDERS
por: Du Plessis, Stéfan, et al.
Publicado: (2020)

S100. EFFECTS OF CANNABIS USE ON BODY MASS, FASTING GLUCOSE AND LIPIDS DURING THE FIRST 12 MONTHS OF TREATMENT IN SCHIZOPHRENIA SPECTRUM DISORDERS
por: Scheffler, Frederika, et al.
Publicado: (2018)

FLUPHENAZINE DECANOATE IN CHRONIC SCHIZOPHRENIA
por: Shukla, G. D.
Publicado: (1981)

Remission of Suicidal Ideation in Emotionally Unstable Personality Disorder with Flupenthixol
por: Chivers, Daniel J., et al.
Publicado: (2022)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
por: Parellada, Eduard, et al.
Publicado: (2012)

Extrapyramidal symptoms predict cognitive performance after first-episode psychosis
por: Lindgren, Maija, et al.
Publicado: (2022)

Nandrolone Decanoate: Use, Abuse and Side Effects
por: Patanè, Federico Giuseppe, et al.
Publicado: (2020)

Akathisia as an Extrapyramidal Side Effect of Fluoxetine
por: Ajufo, Ijeoma, et al.
Publicado: (2021)

Investigating the impact of HIV on patients with first episode psychosis: a study protocol for a longitudinal cohort study
por: Chhagan, Usha, et al.
Publicado: (2021)

Extrapyramidal side effects with low doses of amisulpride
por: Mandal, Nikhiles, et al.
Publicado: (2014)

Exploratory factor structure of the neurological evaluation scale in black africans with first episode schizophrenia
por: Ojagbemi, Akin, et al.
Publicado: (2016)

Addressing the Needs of People with Schizophrenia in South Africa During the COVID-19 Pandemic
por: Thela, Lindokuhle, et al.
Publicado: (2022)

OPEN DRUG TRIAL WITH HALOPERIDOL DECANOATE INJECTIONS IN SCHIZOPHRENIA
por: Varma, V.K., et al.
Publicado: (1989)

Acute Extrapyramidal Side Effects from Smoked Haloperidol
por: Pham, Angeline, et al.
Publicado: (2021)

El decano
por: Gustafsson, Lars
Publicado: (2010)

Long-lasting extrapyramidal symptoms after multiple injections of paliperidone palmitate to treat schizophrenia
por: Takada, Ryohei, et al.
Publicado: (2018)

Two Neuroanatomical Signatures in Schizophrenia: Expression Strengths Over the First 2 Years of Treatment and Their Relationships to Neurodevelopmental Compromise and Antipsychotic Treatment
por: du Plessis, Stefan, et al.
Publicado: (2023)

Management of Psychosis in the Setting of Binge Eating, Mania, and Extrapyramidal Side Effects
por: Tamayo Acosta, Jean C, et al.
Publicado: (2022)

Effect of decanoic acid and 10-hydroxydecanoic acid on the biotransformation of methyl decanoate to sebacic acid
por: Sugiharto, Yohanes Eko Chandra, et al.
Publicado: (2018)

Molecular docking analysis of flupenthixol and desmethylastemizole with the apoptotic regulator proteins CFLAR and TRAF2 linked to lung carcinoma
por: Das, Subrata, et al.
Publicado: (2021)

Decanoic Acid Stimulates Autophagy in D. discoideum
por: Warren, Eleanor C., et al.
Publicado: (2021)

Economic Burden Associated with Extrapyramidal Symptoms in a Medicaid Population with Schizophrenia
por: Abouzaid, Safiya, et al.
Publicado: (2012)

The burden of care, quality of life and depression in relatives of patients with serious mental illness treated at Lentegeur Hospital
por: Nhlabathi, Sihle, et al.
Publicado: (2018)

Pharmacokinetic–Pharmacodynamic Modeling of Severity Levels of Extrapyramidal Side Effects With Markov Elements
por: Pilla Reddy, V, et al.
Publicado: (2012)

Extrapyramidal side-effects of low-dose aripiprazole in an 11-year-old child
por: Mohapatra, Satyakam
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gi31fg88a2r47bctl82p2o6ckv